Skip to content

Clinical trials

Active, not recruiting Breast Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Status: Active, not recruiting Country / region: United States Clear all

513 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20024
20031
20043
20053
20063
20072
20082
20096
20109
201113
20127
201313
201415
201530
201626
201739
201836
201946
202042
202153
202253
202348
202436
202516
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting513

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Memorial Sloan Kettering Cancer Center45
M.D. Anderson Cancer Center37
Dana-Farber Cancer Institute26
City of Hope Medical Center22
AstraZeneca21
National Cancer Institute (NCI)19
Eli Lilly and Company13
Pfizer13
Massachusetts General Hospital11
Abramson Cancer Center at Penn Medicine10

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms513
Triple Negative Breast Neoplasms46
Ovarian Neoplasms37
Colorectal Neoplasms31
Neoplasm Metastasis31
Prostatic Neoplasms31
Lung Neoplasms29
Neoplasms26
Carcinoma, Non-Small-Cell Lung23
Pancreatic Neoplasms21

Trials

Showing 1 to 25 of 513. Each trial links to its page on Pharma Observatory.

413 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.